| Followers | 670 |
| Posts | 86163 |
| Boards Moderated | 0 |
| Alias Born | 05/25/2008 |
Friday, July 03, 2020 12:34:32 AM
nasty wick candle, just know it now has the volume under accumulation
https://www.stockscores.com/chart.asp?TickerSymbol=%20rvvtf%20&TimeRange=1095&Interval=w&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=BB&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=200&Indicator1=RSI&Indicator2=AccDist&Indicator3=MACD&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgrevhub
https://www.stockscores.com/chart.asp?TickerSymbol=%20rvvtf%20&TimeRange=1095&Interval=w&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=BB&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=200&Indicator1=RSI&Indicator2=AccDist&Indicator3=MACD&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgrevhub
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
